WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (AMEX: ILI) reported today that it has entered into a new research agreement with Access Business Group International LLC (ABG), a subsidiary of Alticor Inc. The research agreement encompasses the development of genetic tests to guide consumers’ selection of appropriate skin care products; the further development of tests for weight management and the risk of osteoporosis, as well as the development of other tests. Under the terms of the agreement, Interleukin is eligible to receive up to $2.3 million in additional research funding during 2007.
